Europe: Orphan Drug Products Account for Annual Sales of Over $6 billion Says New Report
Piribo, the online destination for Pharma intelligence, has added a new report.According to the report “Orphan Drug Markets in Europe” the first marketing authorisations for orphan drugs in Europe occurred over 10 years ago. Since then there have been over 60 designated orphan products. These products now account for annual sales of more than $6 billion. According to the report